| Utility: Compounds, salts thereof and methods for treatment of diseases Filling date: 12 Sep 2025 Issue date: 13 Sep 2022 | 20 Aug 2018 | 13 Sep 2022 |
| Utility: SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES Filling date: 12 Sep 2025 Issue date: 4 Aug 2022 | 14 Sep 2021 | 4 Aug 2022 |
| Utility: FORMULATIONS OF PIMAVANSERIN Filling date: 12 Sep 2025 Issue date: 23 Jun 2022 | 14 Mar 2022 | 23 Jun 2022 |
| Utility: METHODS OF TREATING PAIN WITH A THIAZOLINE ANTI-HYPERALGESIC Filling date: 12 Sep 2025 Issue date: 2 Jun 2022 | 3 Nov 2021 | 2 Jun 2022 |
| Utility: Compounds, salts thereof and methods for treatment of diseases Filling date: 12 Sep 2025 Issue date: 31 May 2022 | 21 Feb 2020 | 31 May 2022 |
| Utility: Compounds for Pain Treatment, Compositions Comprising Same, and Methods of Using Same Filling date: 12 Sep 2025 Issue date: 19 May 2022 | 6 Jul 2021 | 19 May 2022 |
| Utility: METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PH- ENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM C Filling date: 12 Sep 2025 Issue date: 27 Jan 2022 | 16 Mar 2021 | 27 Jan 2022 |
| Utility: METHODS OF TREATING DEPRESSION, ANXIETY AND SEXUAL DYSFUNCTION USING THE COMPOUND PIMAVANSERIN Filling date: 12 Sep 2025 Issue date: 20 Jan 2022 | 30 Oct 2019 | 20 Jan 2022 |
| Utility: 5-HT2A SEROTONIN RECEPTOR INVERSE AGONISTS OR ANTAGONISTS FOR USE IN REDUCING AMYLOID-BETA PEPTIDES AND ACCUMULATION OF AMYLOID PLAQUES Filling date: 12 Sep 2025 Issue date: 6 Jan 2022 | 16 Feb 2021 | 6 Jan 2022 |
| Utility: Combination of pimavanserin and cytochrome P450 modulators Filling date: 12 Sep 2025 Issue date: 7 Dec 2021 | 15 Nov 2019 | 7 Dec 2021 |
| Utility: Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent Filling date: 12 Sep 2025 Issue date: 2 Nov 2021 | 10 Mar 2020 | 2 Nov 2021 |
| Utility: Pimavanserin for treating impulse control disorder Filling date: 12 Sep 2025 Issue date: 5 Oct 2021 | 27 Apr 2018 | 5 Oct 2021 |
| Utility: FORMULATIONS OF PIMAVANSERIN Filling date: 12 Sep 2025 Issue date: 16 Sep 2021 | 26 Oct 2020 | 16 Sep 2021 |
| Utility: Compounds for pain treatment, compositions comprising same, and methods of using same Filling date: 12 Sep 2025 Issue date: 17 Aug 2021 | 20 May 2019 | 17 Aug 2021 |
| Utility: METHODS FOR TREATING DEMENTIA RELATED PSYCHOSIS Filling date: 12 Sep 2025 Issue date: 3 Jun 2021 | 1 Dec 2020 | 3 Jun 2021 |
| Utility: COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES Filling date: 12 Sep 2025 Issue date: 29 Apr 2021 | 20 Aug 2018 | 29 Apr 2021 |
| Utility: Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)ph- enylmethyl)carbamide and its tartrate salt and polymorphic form C Filling date: 12 Sep 2025 Issue date: 20 Apr 2021 | 10 Feb 2020 | 20 Apr 2021 |
| Utility: Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)ph- enylmethyl)carbamide and its tartrate salt and polymorphic form Filling date: 12 Sep 2025 Issue date: 20 Apr 2021 | 15 Jan 2020 | 20 Apr 2021 |
| Utility: FORMULATIONS OF PIMAVANSERIN Filling date: 12 Sep 2025 Issue date: 18 Mar 2021 | 27 Aug 2018 | 18 Mar 2021 |
| Utility: Formulations of pimavanserin Filling date: 12 Sep 2025 Issue date: 1 Dec 2020 | 31 Mar 2020 | 1 Dec 2020 |
| Utility: SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES Filling date: 12 Sep 2025 Issue date: 15 Oct 2020 | 18 Nov 2019 | 15 Oct 2020 |
| Utility: COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES Filling date: 12 Sep 2025 Issue date: 27 Aug 2020 | 21 Feb 2020 | 27 Aug 2020 |
| Utility: PIMAVANSERIN ALONE OR IN COMBINATION FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE PSYCHOSIS Filling date: 12 Sep 2025 Issue date: 30 Jul 2020 | 14 Dec 2017 | 30 Jul 2020 |
| Utility: FORMULATIONS OF PIMAVANSERIN Filling date: 12 Sep 2025 Issue date: 16 Jul 2020 | 31 Mar 2020 | 16 Jul 2020 |
| Utility: METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PH- ENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM Filling date: 12 Sep 2025 Issue date: 11 Jun 2020 | 10 Feb 2020 | 11 Jun 2020 |
| Utility: METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PH- ENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM Filling date: 12 Sep 2025 Issue date: 28 May 2020 | 15 Jan 2020 | 28 May 2020 |
| Utility: Formulations of pimavanserin Filling date: 12 Sep 2025 Issue date: 12 May 2020 | 16 Sep 2019 | 12 May 2020 |
| Utility: Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)ph- enylmethyl)carbamide and its tartrate salt and polymorphic form C Filling date: 12 Sep 2025 Issue date: 24 Mar 2020 | 19 Jul 2016 | 24 Mar 2020 |
| Utility: COMBINATION OF PIMAVANSERIN AND CYTOCHROME P450 MODULATORS Filling date: 12 Sep 2025 Issue date: 12 Mar 2020 | 15 Nov 2019 | 12 Mar 2020 |
| Utility: PIMAVANSERIN FOR TREATING IMPULSE CONTROL DISORDER Filling date: 12 Sep 2025 Issue date: 27 Feb 2020 | 27 Apr 2018 | 27 Feb 2020 |
| Utility: FORMULATIONS OF PIMAVANSERIN Filling date: 12 Sep 2025 Issue date: 9 Jan 2020 | 16 Sep 2019 | 9 Jan 2020 |
| Utility: Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases Filling date: 12 Sep 2025 Issue date: 7 Jan 2020 | 26 Jun 2018 | 7 Jan 2020 |
| Utility: Combination of pimavanserin and cytochrome P450 modulators Filling date: 12 Sep 2025 Issue date: 31 Dec 2019 | 9 Apr 2019 | 31 Dec 2019 |
| Utility: Formulations of pimavanserin Filling date: 12 Sep 2025 Issue date: 22 Oct 2019 | 25 Mar 2019 | 22 Oct 2019 |
| Utility: COMBINATION OF PIMAVANSERIN AND CYTOCHROME P450 MODULATORS Filling date: 12 Sep 2025 Issue date: 1 Aug 2019 | 9 Apr 2019 | 1 Aug 2019 |
